The therapeutic target against memory impairments in Down syndrome gains strength

by UPF - Universitat Pompeu Fabra

The experimental, long-term pharmacological treatment in a mice model for Down syndrome to reduce the activity of cannabinoid receptor 1 improves the memory defects associated with the syndrome even w...

Read more

Positive results of the clinical trial of a drug to improve cognitive function in Down syndrome

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Phase 1/2 of the clinical trial shows that the administration of the AEF0217 molecule developed by the biotech Aelis Farma, is safe and can improve key skills such as communication, social interaction...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream